Med-Lake Laboratory, LLC

Med-Lake Laboratory, LLC was paid $14.16M by Medicaid between Aug 2019 and Dec 2024, across 154 billing codes. Its largest line is G0482, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed — 25% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Georgia

Rank by total paid#4 of 66

Median peer was paid$178K

This provider vs. median80×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2019	1,198	$17K
2020	46,160	$1.09M
2021	121,588	$3.65M
2022	119,035	$3.74M
2023	132,237	$3.20M
2024incomplete	117,113	$2.46M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	25%	59,063	32,936	$3.57M
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	23%	61,754	42,035	$3.26M
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	19%	112,305	64,189	$2.66M
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	11%	48,501	32,619	$1.51M
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	2.8%	3,658	2,844	$396K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	2.7%	24,513	9,695	$386K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	2.0%	1,581	1,331	$284K
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	1.2%	2,609	1,836	$164K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	7,629	6,518	$103K
84443	Thyroid stimulating hormone (TSH)	<1%	10,755	9,241	$79K
80053	Comprehensive metabolic panel	<1%	14,584	12,488	$71K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	8,714	3,933	$66K

142 more codes

80061	Lipid panel	<1%	11,125	$64K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	3,260	$62K
80074		<1%	3,373	$60K
82607		<1%	6,147	$46K
83036	Hemoglobin; glycosylated (A1C)	<1%	8,919	$41K
82728		<1%	4,660	$39K
87640		<1%	2,262	$36K
87581		<1%	1,616	$35K
87486		<1%	1,605	$34K
82746		<1%	4,059	$34K
84481		<1%	2,946	$33K
87529		<1%	997	$32K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	9,507	$32K
83992		<1%	1,696	$28K
84403		<1%	1,846	$27K
83090		<1%	1,998	$27K
80353		<1%	1,674	$25K
80371		<1%	1,662	$25K
80361		<1%	1,698	$25K
80365		<1%	1,674	$25K
80349		<1%	1,701	$25K
80359		<1%	1,672	$25K
80348		<1%	1,791	$25K
80373		<1%	1,672	$25K
80369		<1%	1,684	$25K
80358		<1%	1,669	$25K
80368		<1%	1,687	$25K
80346		<1%	1,688	$25K
80372		<1%	1,660	$25K
80357		<1%	1,657	$24K
80354		<1%	1,694	$24K
80366		<1%	1,686	$24K
82670		<1%	1,227	$24K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	1,545	$23K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	2,612	$23K
80320		<1%	1,521	$23K
80325		<1%	1,573	$23K
80364		<1%	1,518	$23K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	1,462	$22K
81025		<1%	4,873	$22K
82610		<1%	1,251	$21K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	1,437	$21K
86141		<1%	1,946	$21K
83525		<1%	1,993	$19K
80050	General health panel	<1%	640	$16K
84144		<1%	996	$16K
83735		<1%	2,949	$14K
82627		<1%	958	$14K
83540		<1%	3,216	$13K
86780		<1%	2,233	$13K
87563		<1%	929	$12K
84439		<1%	3,079	$12K
86341		<1%	1,342	$11K
87498		<1%	649	$11K
83695		<1%	1,850	$11K
83001		<1%	627	$10K
87806		<1%	396	$10K
83002		<1%	551	$9K
87522	Neg quan hep c or qual rna	<1%	543	$9K
86708		<1%	1,850	$9K
84550		<1%	2,662	$9K
87511		<1%	439	$7K
83615		<1%	1,255	$7K
85014		<1%	5,091	$6K
85018		<1%	5,072	$6K
84480		<1%	1,072	$6K
87481		<1%	429	$5K
80048	Basic metabolic panel (calcium, ionized)	<1%	1,131	$5K
87653		<1%	421	$5K
82977		<1%	1,428	$5K
84270		<1%	367	$4K
84466		<1%	742	$4K
85027		<1%	1,256	$4K
83550		<1%	1,380	$3K
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	531	$3K
80076		<1%	798	$3K
83721		<1%	1,036	$2K
80051		<1%	847	$2K
81001		<1%	1,587	$2K
84436		<1%	931	$2K
87086	Culture, bacterial; quantitative colony count, urine	<1%	587	$2K
87500		<1%	126	$2K
80345		<1%	148	$2K
80362		<1%	181	$2K
80324		<1%	142	$2K
82248		<1%	803	$2K
80321		<1%	146	$2K
82310		<1%	875	$2K
87631		<1%	95	$1K
84460		<1%	762	$1K
84450		<1%	761	$1K
84075		<1%	748	$1K
82247		<1%	748	$1K
82040		<1%	749	$1K
80164		<1%	376	$1K
84520		<1%	861	$1K
82947		<1%	874	$1K
84146		<1%	237	$1K
84155		<1%	749	$961.94
87150		<1%	38	$950.51
84311		<1%	391	$923.48
86803		<1%	166	$778.77
80177		<1%	85	$759.35
82626		<1%	102	$676.80
84702		<1%	141	$651.96
86696		<1%	108	$606.74
82043		<1%	408	$558.17
85004		<1%	233	$555.84
86769		<1%	19	$535.48
80178		<1%	232	$478.20
86695		<1%	107	$408.37
82465		<1%	117	$404.60
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	17	$348.88
87077		<1%	104	$298.00
87641		<1%	28	$288.42
82570		<1%	291	$284.46
82615		<1%	102	$255.90
84100		<1%	107	$255.88
84478		<1%	114	$215.95
84153		<1%	21	$197.23
82533		<1%	16	$187.00
87340		<1%	58	$178.74
36415	Collection of venous blood by venipuncture	<1%	841	$172.19
87186		<1%	60	$144.60
82565		<1%	56	$143.68
82550		<1%	13	$64.00
86706		<1%	20	$62.86
83718		<1%	71	$55.22
85651		<1%	32	$52.14
81003		<1%	30	$51.94
87088		<1%	21	$46.93
84132		<1%	25	$39.59
82374		<1%	23	$34.16
82435		<1%	23	$32.23
83986		<1%	79	$4.48
80335		0%	27	$0.00
80338		0%	27	$0.00
80360		0%	19	$0.00
80332		0%	27	$0.00
80355		0%	34	$0.00
80356		0%	21	$0.00
80342		0%	17	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMOSS, JENNIFER (BILLING MANAGER)